Related Experiment Video
Updated: Nov 2, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Cardio-oncology Training in the COVID-19 Era
Stephanie Feldman1, Jennifer Liu1,2, Richard Steingart1,2
1Cardiology Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
Cardio-oncology training must adapt to COVID-19 challenges, offering new opportunities for this emerging field. Lessons learned will shape future education for cancer and cardiovascular disease patient care.
Area of Science:
- Cardio-oncology
- Medical Education
- Infectious Disease Epidemiology
Background:
- Cardio-oncology focuses on cardiovascular health in cancer patients.
- Structured training in this emerging field is limited.
- The COVID-19 pandemic significantly impacts healthcare and medical training.
Purpose of the Study:
- To analyze the impact of the COVID-19 pandemic on cardio-oncology training.
- To provide strategies for adapting training programs and trainees.
- To identify lasting benefits of pandemic-era adaptations for future cardio-oncology education.
Main Methods:
- Review of the effects of the COVID-19 pandemic on cardio-oncology training.
- Discussion of challenges and adaptive strategies for training programs.
- Exploration of opportunities for innovation in medical education.
Main Results:
- The COVID-19 pandemic presents unique challenges and risks to cardio-oncology trainees and patients.
- Novel opportunities for remote learning and flexible training models have emerged.
- Adaptations are necessary to ensure continued high-quality education.
Conclusions:
- The COVID-19 pandemic necessitates a re-evaluation of cardio-oncology training requirements.
- Flexible and innovative approaches to training are crucial for the field's growth.
- Lessons from the pandemic can enhance future cardio-oncology education and patient care.
More Related Videos
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Introduction Cardiac Emergencies
Cardiomyopathy VII: Pre and Post Operative Nursing Management